1-substituted-2-(N-pheny l-N-(phenylmethyl)methanamine)-4,5-dihy

Details 1-substituted-2-(N-pheny l-N-(phenylmethyl)methanamine)-4,5-dihy 1-substituted-2-(N-pheny l-N-(phenylmethyl)methanamine)-4,5-dihy

1991-05-23

1994-03-22

Higel, Floyd D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514401, 514400, 5483355, 5483401, 5483481, 5483491, 546278, C07D23324, C07D23360, C07D23361, C07D40106, A61K 31415, A61K 3144

Patent

active

052964930

ABSTRACT:
The present patent application discloses compounds of the formula ##STR1## wherein R.sup.1 is C.sub.1-10 saturated or unsaturated alkyl; or ##STR2## wherein R'" is H or ##STR3## R.sup.2 is phenyl which is unsubstituted or substituted one or more times with halogen, CF.sub.3, C.sub.1-6 -alkoxy, NO.sub.2, CO.sub.2 --C.sub.1-6 -alkyl, methyl; benzyl which may be substituted one or more times with halogen, CF.sub.3, C.sub.1-6 -alkoxy, NO.sub.2, CO.sub.2 --C.sub.1-6 -alkyl, methyl; pyridyl; or cyclohexyl;

REFERENCES:
B. K. Siesjo et al., Journal of Cerebral Blood Flow and Metabolism, 9, 127-140 (1989).
B. K. Siesjo, NIPS, 5, 120-125 (1990).
Winifred G. Nayler, Calcium Antagonists, Academic Press, pp. 259, and 293-297 (1988).
Merck Index (11th Edition), entry 709 on p. 107 (1989).

Affiliated with

Also associated with

Rating

1-substituted-2-(N-pheny l-N-(phenylmethyl)methanamine)-4,5-dihy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-substituted-2-(N-pheny l-N-(phenylmethyl)methanamine)-4,5-dihy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-substituted-2-(N-pheny l-N-(phenylmethyl)methanamine)-4,5-dihy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-437324